Emergence of Medetomidine in the Illicit Drug Supply: Implications for Emergency Care and Withdrawal Management

Read full text
Authors: Michael J. Lynch, Anthony F. Pizon, D.M. Yealy
Cited by: 10
References: 37

Abstract

The US illicit drug supply continues to evolve with increasingly dangerous adulterants, with medetomidine a new agent seen in acute care and other practice settings. We reviewed available literature on illicit drug adulterants, medetomidine intoxication, and sequelae. Although little is known about withdrawal and the clinical manifestations are stark, we reviewed the best available literature on dexmedetomidine withdrawal and suggest approaches for treatment.

Fields of Study & Subjects

Anesthesia and Sedative Agents Poisoning and overdose treatments Veterinary Pharmacology and Anesthesia

Publication details

Journal / source
Annals of Emergency Medicine
Publisher
Elsevier BV
Volume
87
Issue
6
Pages
709–716
Publication date
23 January 2026
Language
EN